NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Friday.

According to Zacks, “Nissan Chemical Industries, Ltd. engaged in the manufacture and sale of industrial chemicals. Its operating segments include Chemicals, Functional Materials, Agrochemicals, Pharmaceuticals, Wholesale Business and Others. The Chemicals segment deals with fine and basic chemicals which consists of melamine, sulfuric and nitric acid, ammonia and epoxy compound. The Functional Materials segment produces display, semiconductor and inorganic materials. The Agrochemicals segment markets herbicides, insecticides and fungicide. The Pharmaceuticals segment offers anti-cholesterol agent and custom chemicals. The Wholesale Business segment handles chemical trading. The Others segment includes fertilizers, transportation, landscaping and engineering. Nissan Chemical Industries, Ltd is headquartered in Tokyo, Japan. “

NNCHY opened at $50.05 on Friday. The firm has a market capitalization of $6.60 billion, a P/E ratio of 30.71, a P/E/G ratio of 1.83 and a beta of 1.04. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.85 and a current ratio of 2.87. NISSAN CHEM IND/ADR has a 12-month low of $36.81 and a 12-month high of $46.74.

About NISSAN CHEM IND/ADR

Nissan Chemical Corporation engages in chemicals, performance materials, agricultural chemicals, pharmaceuticals, and advanced materials and planning businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, a urea solution; FINEOXOCOL, a saturated fatty alcohol and acid; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a flame retardant; Nissan Reishi, a health food; PHOSMEL, a non-halogen flame retardants, phenylphosphonic acid, a surface modifier; and HI-LITE, a chlorinated isocyanulate.

Recommended Story: Earnings Per Share

Get a free copy of the Zacks research report on NISSAN CHEM IND/ADR (NNCHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NISSAN CHEM IND/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NISSAN CHEM IND/ADR and related companies with MarketBeat.com's FREE daily email newsletter.